| Patents for C07J 7 - Normal steroids containing carbon, hydrogen, halogen, or oxygen, substituted in position 17 beta by a chain of two carbon atoms (2,018) |
|---|
| 05/15/2002 | CN1084617C Combination treatment for osteoporosis |
| 05/10/2002 | WO2002036106A2 Novel medicament compositions based on anticholinergics and corticosteroids |
| 05/10/2002 | WO2001029036A3 Allosteric sites on muscarinic receptors |
| 05/10/2002 | WO2001026618A3 Composition, especially a cosmetic composition, containing a steroid and a liposoluble uv filter |
| 05/08/2002 | CN1348461A 17 beta-acyl-17 alpha-propynyl-11 beta-arylsteroids and their derivatives having agonist or antagonist hormonal properties |
| 05/02/2002 | WO2001074840A3 17-alpha-substituted-11-beta-substituted-4-aryl and 21-substituted 19-norpregna 21-substituted 19-norpregnadienedione as antiprogestational agents |
| 05/02/2002 | WO2001049280A3 Weight promoting composition, method, and product |
| 04/25/2002 | WO2002032432A1 Use of antiprogestins for the induction of apoptosis in a cell |
| 04/25/2002 | WO2002032430A1 Use of antiprogestins for prophylaxis and treatment of hormone-dependent diseases |
| 04/23/2002 | US6376657 Pharmaceutical compositions having appetite suppressant activity |
| 04/17/2002 | EP1033991B1 Mometasone furoate suspensions for nebulization |
| 04/11/2002 | WO2001032680A3 18-nor-steroids as selectively active estrogens |
| 04/10/2002 | CN1344272A Method for producing 4,4-dimethyl-3 beta-hydroxypregna-8, 14-diene-21-carboxylic acid esters and intermediate products obtained by said method |
| 04/03/2002 | EP0988312B1 17beta-allyloxy(thio)alkyl-androstane derivatives for the modulation of meiosis |
| 03/27/2002 | CN1341603A Synthesis method of pregnen ketoalcohol compound |
| 03/21/2002 | WO2001051055A3 Pharmaceutical compositions containing steroidal structures and uses thereof |
| 03/14/2002 | US20020032340 Antitumor and antirheumatic agents, high binding afinity to vitamin D receptors and weak hypercalcemic activity |
| 02/28/2002 | US20020025951 Urogenital disorders |
| 02/07/2002 | WO2002009683A2 Aldosterone blocker therapy to prevent or treat inflammation-related disorders |
| 02/07/2002 | CA2416152A1 Aldosterone blocker therapy to prevent or treat inflammation-related disorders |
| 01/30/2002 | CN1333212A pregnanedione compound, preparation method and use |
| 01/16/2002 | EP0923599B1 Process for the preparation of 17-esters of 9alpha,21-dihalo-pregnane-11beta,17alphadiol-20-ones |
| 01/16/2002 | CN1077894C Process for preparing dieneketonol acetate |
| 01/09/2002 | CN1330659A Pregnane glucuronides compound |
| 01/03/2002 | US20020002295 Novel (meth) acrylic acid ester compound |
| 01/03/2002 | US20020002155 Glucocorticoids; antiimflammatory and immunosuppressive agents |
| 01/02/2002 | EP1166792A2 Extracts, compounds & pharmaceutical compositions having anti-diabetic activity and their use |
| 12/27/2001 | WO2001098322A1 Novel steroidal antiestrogens and antiandrogens and uses thereof |
| 12/27/2001 | WO2001097860A2 Pharmaceuticals for the imaging of angiogenic disorders for use in combination therapy |
| 12/27/2001 | CA2413328A1 Pharmaceuticals for the imaging of angiogenic disorders for use in combination therapy |
| 12/26/2001 | CN1328489A Milling process for production of finely milled medicinal substances |
| 12/20/2001 | WO2001096293A1 Vitamin d derivatives |
| 12/19/2001 | EP1163257A1 Method for producing 4,4-dimethyl-3beta-hydroxypregna-8,14-diene-21-carboxylic acid esters and intermediate products obtained by said method |
| 12/18/2001 | US6331534 Steroids as neurochemical stimulators of the VNO to alleviate pain |
| 12/04/2001 | US6326503 Antitumor agents |
| 11/28/2001 | EP0941361B1 A method for the preparation of steroid compounds |
| 11/14/2001 | CN1322210A High purity composition comprising (7a, 17a,)-17-hydroxy-7-methyl 19-nor-17-prege-5-(10)-en-20-yn-3-one |
| 11/07/2001 | EP1150683A1 Utilization of dienogest in high doses |
| 11/07/2001 | CN1321166A Propanolamine derivs. linked with bile acid used for treating disorders of lipid metabolism |
| 10/31/2001 | EP1149839A1 Progesterone substantially free of delta14-pregnene-3,20-dione |
| 10/24/2001 | EP1146964A1 Milling process for the production of finely milled medicinal substances |
| 10/11/2001 | WO2001074840A2 17-alpha-substituted-11-beta-substituted-4-aryl and 21-substituted 19-norpregna 21-substituted 19-norpregnadienedione as antiprogestational agents |
| 10/10/2001 | EP1140972A1 New 7-alpha, 17-alpha-bis-alkylated testosterone derivatives and their use in long-term therapy of androgen-dependent diseases |
| 09/27/2001 | WO2001070234A1 Anaesthetic composition |
| 09/26/2001 | EP1135404A1 Sterol phosphates used as deodorant substances |
| 09/26/2001 | EP1135403A1 17beta-acyl-17alpha-propynyl-11beta-arylsteroids and their derivatives having agonist or antagonist hormonal properties |
| 08/28/2001 | US6281204 19-nor steroids having a thiocarbonated chain in position 11beta, their preparation process and the intermediates of this process, and the intermediates of this process, their use as medicaments and compositions |
| 08/28/2001 | CA2191324C Process for preparing .delta.9,11 and 21-chloro corticosteroids |
| 08/21/2001 | US6277838 Methods for allosteric modulation of the GABA receptor by members of the androstane and pregnane series |
| 08/14/2001 | US6274572 Pregnane derivatives with no alpha-17 substitutent, their medicinal use, manufacturing method and its intermediaries and related compounds |
| 08/08/2001 | EP1121376A1 Pregnane glucuronides |
| 08/08/2001 | EP1121375A1 High purity composition comprising (7alpha,17alpha)- 17-hydroxy- 7-methyl- 19-nor-17-pregn- 5(10)-en-20-yn-3-one |
| 08/07/2001 | US6271220 Anticancer, antiarthritic agents |
| 08/02/2001 | WO2001055171A1 Mometasone and its preparation |
| 07/26/2001 | WO2001052856A2 Use of dehydroepiandrosterone, its precursors and derivatives, by oral administration, as hydrating agents with direct action |
| 07/25/2001 | EP1117676A1 Propanolamine derivatives linked with bile acid used for treating disorders of the lipid metabolism |
| 07/19/2001 | WO2001051055A2 Pharmaceutical compositions containing steroidal structures and uses thereof |
| 07/19/2001 | CA2396098A1 Pharmaceutical compositions containing steroidal structures and uses thereof |
| 07/17/2001 | US6262282 17β-allyloxy(thio)alkyl-androstane derivatives for the modulation of meiosis |
| 07/12/2001 | WO2001049280A2 Weight promoting composition, method, and product |
| 07/05/2001 | WO2001047945A1 Process for preparing 17alpha-acetoxy-11beta-[4-n,n-(dimethylamino)phenyl]-21-methoxy-19-norpregna-4,9-diene-3,20-dione, intermediates useful in the process, and processes for preparing such intermediates |
| 07/05/2001 | US20010006962 Behavior of biologically active compounds favorably modified by replacing a functional group with an unsaturated fatty derivative, e.g. elaidic acid; bioavailability; membrane passage; organ targeting; drugs; agriculture |
| 06/28/2001 | WO2001045677A1 Process for producing nanometer particles by fluid bed spray-drying |
| 06/28/2001 | WO2001045674A1 Process for producing nanometer particles by fluid bed spray-drying |
| 06/26/2001 | US6251887 17β-aryl(arylmethyl)oxy(thio)alkyl-androstane derivatives |
| 06/05/2001 | US6242619 19-norpregnane steroids as neurochemical initiators of change in human hypothalamic function |
| 05/16/2001 | EP1099444A1 Gastric acid secretion |
| 05/10/2001 | WO2001032680A2 18-nor-steroids as selectively active estrogens |
| 04/27/2001 | CA2324538A1 Gastric acid secretion |
| 04/26/2001 | WO2001029036A2 Allosteric sites on muscarinic receptors |
| 04/26/2001 | CA2386149A1 Allosteric sites on muscarinic receptors |
| 04/19/2001 | WO2001026618A2 Composition, especially a cosmetic composition, containing a steroid and a liposoluble uv filter |
| 04/19/2001 | CA2355357A1 Composition, especially a cosmetic composition, containing a steroid and a liposoluble uv filter |
| 04/18/2001 | EP1092423A2 Use of DHEA or its precursors and metabolites as skin depigmentation agents |
| 03/27/2001 | USRE37116 Nitrosated and nitrosylated compounds, and compositions and their use for treating respiratory disorders |
| 03/06/2001 | US6197762 Nitrosated and nitrosylated steroids compositions, and methods for treating respiratory disorders |
| 02/28/2001 | EP1077765A1 Photochemical and thermochemical solar syntheses using flat-bed solar collectors/solar reactors |
| 02/27/2001 | US6194565 Antiinflammatory agent |
| 02/27/2001 | CA2188907C Combination compound for contraception based on natural estrogen |
| 02/27/2001 | CA2081205C Steroids which inhibit angiogenesis |
| 02/14/2001 | EP0663924B1 17-beta-carboxanilides of 4-aza-5-alpha-androstan-3-ones as 5-alpha-reductase inhibitors |
| 02/14/2001 | CN1061985C Method for prepn of progestol by degradation of steroidal saponin and its use |
| 02/14/2001 | CN1061983C 4-trifluoromethyl-3-ketosteroid compound and synthesizing method thereof |
| 02/13/2001 | US6187767 Methods for preventing progressive tissue necrosis, reperfusion injury, bacterial translocation and adult respiratory distress syndrome |
| 02/06/2001 | US6184398 16-ene-vitamin D derivatives |
| 01/30/2001 | US6180803 Steroid drugs |
| 01/30/2001 | US6180618 Propanolamine derivatives linked to bile acids, processes for their preparation, pharmaceuticals comprising these compounds, and their use |
| 01/24/2001 | EP1070082A1 Method for producing 4,4-dimethyl-5alpha-cholesta-8,14,24-triene-3beta-ol and intermediate products obtained by said method |
| 01/24/2001 | CN1061052C 11 Beta-aromatic group-4-estraene and acid additive salt application in medicine |
| 01/17/2001 | EP0808325B1 Androstane and pregnane series for allosteric modulation of gaba receptor |
| 01/09/2001 | US6172052 17β-acyl-17α-propynyl-11β-arylsteroids and their derivatives having agonist or antagonist hormonal properties |
| 12/19/2000 | CA2014759C Novel steroid derivatives |
| 12/12/2000 | US6160139 Process for the oxidation of pseudodiosgenin diacetate to diosone for the production of 16-dehydropregnenolone acetate |
| 12/05/2000 | CA2027627C Process for preparing 21-desoxyprednisolone 17-esters |
| 11/30/2000 | WO2000021511A3 Subcutaneous medroxyprogesterone acetate for treatment of menopause and endometriosis |
| 11/22/2000 | EP1052980A1 Subcutaneous medroxyprogesterone acetate for treatment of menopause and endometriosis |
| 11/22/2000 | CN1058724C Use of steroid compound for preparing medicaments |
| 11/21/2000 | US6150348 Methods for preventing progressive tissue necrosis, reperfusion injury, bacterial translocation and adult respiratory distress syndrome |
| 11/07/2000 | US6143736 Methods, compositions, and compounds for allosteric modulation of the GABA receptor by members of the androstane and pregnane series |
| 10/17/2000 | US6133280 Androgen synthesis inhibitors |